Osteosarcoma of the jaw bones

• Published in: British journal of oral & maxillofacial surgery Vol. 35; no. 5; pp. 357 - 362
• Main Authors: Doval, D.C., Kumar, R.V., Kannan, V., Sabitha, K.S., Misra, S., Kumar, M.Vijay, Hegde, P., Bapsy, P.P., Mani, K., Shenoy, A.M., Kumarswamy, S.V.
• Format: Journal Article
• Language: English
• Published: Londonc Elsevier Ltd 01-10-1997; Elsevier
• Subjects: Adult; Antineoplastic Agents - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Cause of Death; Chondrocytes - pathology; Cisplatin - administration & dosage; Combined Modality Therapy; Dentistry; Disease-Free Survival; Facial bones, jaws, teeth, parodontium: diseases, semeiology; Female; Fibroblasts - pathology; Follow-Up Studies; Humans; Male; Mandibular Neoplasms - diagnostic imaging; Mandibular Neoplasms - pathology; Mandibular Neoplasms - therapy; Maxillary Neoplasms - diagnostic imaging; Maxillary Neoplasms - pathology; Maxillary Neoplasms - therapy; Medical sciences; Neoplasm Recurrence, Local - pathology; Osteoblasts - pathology; Osteolysis - diagnostic imaging; Osteosarcoma - diagnostic imaging; Osteosarcoma - pathology; Osteosarcoma - therapy; Osteotomy; Otorhinolaryngology. Stomatology; Palliative Care; Radiography; Retrospective Studies; Tumors; Human; Mandible; Radiodiagnosis; Stomatology; Superior maxillary; Diseases of the osteoarticular system; Malignant tumor; Review; Epidemiology; Survival; Retrospective; Radiography; Pathology; Symptomatology; Chemotherapy; Histopathology; Treatment; Exeresis; Osteosarcoma; Surgery; Diagnosis; Bone; Maxillary disease
• ISSN: 0266-4356; 1532-1940
• DOI: 10.1016/S0266-4356(97)90410-1

Osteosarcoma of the jaw bone is comparatively rare and accounts for about 6.5% of all osteosarcomas. We treated eight cases of osteosarcoma of the jaw bone involving the mandible and maxilla in equal proportions between 1986–1992. The median age was 31 years and male: female ratio was 5:3. Swelling and bony expansion were the most common presentations. Radiologically six patients had lytic lesions, and histopathologically they were osteoblastic (n = 4), chondroblastic (n = 3) and fibroblastic (n =1 ). Three patients, two with mandibular and one with maxillary osteosarcoma underwent radical surgery and six courses of cisplatinum-based chemotherapy. All were alive and disease free 24, 30, and 54 months after treatment. Histologically all three were chondroblastic. Five patients had incomplete or palliative treatment. All patients died of progressive or locally recurrent disease within 2 years.